Case number 2023-2424
Seagen Inc. v. Daiichi Sankyo Company, Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 7, 2025 | 0 | SEAGEN INC. v. DAIICHI SANKYO COMPANY, LTD. [OPINION] [precedential] (0) |
| Aug 21, 2025 | 68 | NOTICE OF ORAL ARGUMENT. Panel: 2510I. Case scheduled October 6, 2025. Response to Notice of Oral Argument due: 09/04/2025. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1109734] [CDL] [Entered: 08/21/2025 03:35 PM] (2) |
| Apr 25, 2025 | 67 | The following conflict dates submitted by Christopher Neil Sipes for AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Company, Ltd. and AstraZeneca UK Ltd. have been accepted by the court: 06/06/2025, 06/09/2025, 08/08/2025, 08/11/2025. [1085144] [MJL] [Entered: 04/25/2025 12:09 PM] (0) |
| Apr 24, 2025 | 66 | Notice from Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. regarding conflicts with oral argument. Service: 04/24/2025 by email. [1084995] [23-2424] [Christopher Sipes] [Entered: 04/24/2025 05:14 PM] (4) |
| Apr 24, 2025 | 65 | The following conflict dates requested on behalf of Seagen Inc.'s client representative (see Doc. No. [62]) are not accepted at this time: 06/06/2025, 06/09/2025. Please review the Guidance on Oral Argument Scheduling Conflicts for more information. [1084814] [MJL] [Entered: 04/24/2025 10:30 AM] (0) |
| Apr 24, 2025 | 64 | The following conflict dates submitted by Sara Tonnies Horton for Seagen Inc. have been accepted by the court: 06/02/2025, 06/03/2025, 06/04/2025, 06/05/2025, 07/07/2025, 07/08/2025, 07/09/2025, 07/10/2025, 07/11/2025, 07/14/2025. [1084813] [MJL] [Entered: 04/24/2025 10:27 AM] (0) |
| Apr 24, 2025 | 63 | The following conflict dates requested by Christopher Neil Sipes for AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Company, Ltd. and AstraZeneca UK Ltd. (see Doc. No. [61]) are not accepted at this time: 06/06/2025, 06/09/2025, 08/08/2025, 08/11/2025. Please review the Guidance on Oral Argument Scheduling Conflicts for more information. [1084811] [MJL] [Entered: 04/24/2025 10:22 AM] (0) |
| Apr 21, 2025 | 62 | Notice from Appellee Seagen Inc. regarding conflicts with oral argument. Service: 04/21/2025 by email. [1083984] [23-2424] [Sara Horton] [Entered: 04/21/2025 07:26 PM] (3) |
| Apr 21, 2025 | 61 | Notice from Appellants Daiichi Sankyo Company, Ltd., AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. regarding conflicts with oral argument. Service: 04/21/2025 by email. [1083972] [23-2424] [Christopher Sipes] [Entered: 04/21/2025 06:24 PM] (4) |
| Apr 14, 2025 | 60 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [1082386] [IMH] [Entered: 04/14/2025 02:50 PM] (1) |
| Apr 14, 2025 | 59 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [1082380] [IMH] [Entered: 04/14/2025 02:46 PM] (1) |
| Mar 11, 2025 | 58 | Notice from Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. Notice of Withdrawal of Non-Principal Counsel. Service: 03/11/2025 by email. [1074693] [23-2424] [Adam Mitchell] [Entered: 03/11/2025 08:40 PM] (2) |
| Mar 4, 2025 | 57 | 6 paper copies of Doc. No. [53], [47], [29] received from Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. [1074027] [JCP] [Entered: 03/07/2025 04:31 PM] (0) |
| Feb 27, 2025 | 56 | 6 paper copies of Doc. No. [37] received from Appellee Seagen Inc.. [1072657] [VDW] [Entered: 03/03/2025 03:13 PM] (0) |
| Feb 25, 2025 | 55 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [1071383] [IMH] [Entered: 02/25/2025 03:05 PM] (0) |
| Aug 6, 2024 | 54 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 08/06/2024 by email. [1023088] --[Edited 08/13/2024 by GWK - Reason: compliance review complete] [Christopher Sipes] [Entered: 08/06/2024 11:56 AM] (2649) |
| Aug 6, 2024 | 53 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 08/06/2024 by email. [1023082]--[Edited 08/13/2024 by GWK - Reason: compliance review complete] [Christopher Sipes] [Entered: 08/06/2024 11:47 AM] (0) |
| Aug 1, 2024 | 52 | NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd., Appendix, Confidential Appendix, Certificate of Service [49], [50], [51], is not in compliance with the rules of this court (see attached). Compliant document due on 08/08/2024. Service as of this date by the Clerk of Court. [1022150] [GWK] [Entered: 08/01/2024 12:25 PM] (2) |
| Jul 29, 2024 | 51 | Certificate of Service for Confidential Joint Appendix for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 07/29/2024 by email. [1021252] [23-2424] This document is non-compliant. See Doc No. [52] [Christopher Sipes] [Entered: 07/29/2024 11:00 PM] (2) |
| Jul 29, 2024 | 50 | APPENDIX FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 07/29/2024 by email. [1021251] [23-2424] This document is non-compliant. See Doc No. [52] [Christopher Sipes] [Entered: 07/29/2024 10:56 PM] (2649) |
| Jul 29, 2024 | 49 | CONFIDENTIAL APPENDIX FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 07/29/2024 by email. [1021248] [23-2424] This document is non-compliant. See Doc No. [52] [Christopher Sipes] [Entered: 07/29/2024 09:45 PM] (0) |
| Jul 22, 2024 | 48 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 07/22/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1019757] --[Edited 07/30/2024 by GWK - Reason: compliance review complete] [Christopher Sipes] [Entered: 07/22/2024 10:46 PM] (44) |
| Jul 22, 2024 | 47 | MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 07/22/2024 by email. [1019756]--[Edited 07/30/2024 by GWK - Reason: compliance review complete] [Christopher Sipes] [Entered: 07/22/2024 10:41 PM] (0) |
| Jul 19, 2024 | 46 | ORDER filed granting the motions [43] [1010413-2] to the following extent: The above-captioned appeals shall be considered companion cases and assigned to the same merits panel, the respec-tive due dates for briefing are unchanged, and Daiichi will not be granted extensions of time for its briefing. Service as of this date by the Clerk of Court. [1019167] [23-2424, 24-1878] [LMS] [Entered: 07/19/2024 03:15 PM] (3) |
| Jun 28, 2024 | 45 | REPLY of Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. to response [44]. Service: 06/28/2024 by email. [1014364] [23-2424] [Christopher Sipes] [Entered: 06/28/2024 05:19 PM] (11) |
| Jun 21, 2024 | 44 | RESPONSE of Appellee Seagen Inc. to Doc No. [43]. Service: 06/21/2024 by email. [1012602] [23-2424] [Sara Horton] [Entered: 06/21/2024 03:50 PM] (22) |
| Jun 11, 2024 | 43 | MOTION of Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. to treat as companion cases. Service: 06/11/2024 by email. [1010273] [23-2424] [Christopher Sipes] [Entered: 06/11/2024 02:37 PM] (22) |
| Jun 11, 2024 | 42 | Notice of Related Case Information for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 06/11/2024 by email. [1010268] [23-2424] [Christopher Sipes] [Entered: 06/11/2024 02:32 PM] (3) |
| May 17, 2024 | 41 | ORDER granting motion to extend time to file brief [40] filed by Appellants; The reply brief is due 07/22/2024. No further extensions of time for the reply brief should be anticipated. Service as of this date by the Clerk of Court. [1004931] [LMS] [Entered: 05/17/2024 01:06 PM] (2) |
| May 9, 2024 | 40 | MOTION of Appellants Daiichi Sankyo Company, Ltd., AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to extend the time to 07/22/2024 to file brief. Service: 05/09/2024 by email. [1003367] [23-2424] [Christopher Sipes] [Entered: 05/09/2024 05:09 PM] (12) |
| May 2, 2024 | 39 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellee Seagen Inc.. Service: 05/02/2024 by email. [1001736] --[Edited 05/09/2024 by GWK - compliance review complete] [Sara Horton] [Entered: 05/02/2024 07:32 PM] (82) |
| May 2, 2024 | 38 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Seagen Inc., Response Brief [36], is not in compliance with the rules of this court (see attached). Compliant document due on 05/09/2024. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [1001708] [GWK] [Entered: 05/02/2024 04:37 PM] (2) |
| May 1, 2024 | 37 | MODIFIED ENTRY: CONFIDENTIAL RESPONSE BRIEF FILED by Appellee Seagen Inc.. Service: 05/01/2024 by email. [1001416]--[Edited 05/02/2024 by GWK - compliance review complete] [Sara Horton] [Entered: 05/01/2024 04:16 PM] (0) |
| May 1, 2024 | 36 | RESPONSE BRIEF FILED by Appellee Seagen Inc.. Service: 05/01/2024 by email. [1001415] [23-2424] This document is non-compliant. See Doc No. [38] [Sara Horton] [Entered: 05/01/2024 04:15 PM] (82) |
| Apr 3, 2024 | 35 | Notice of Related Case Information for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 04/03/2024 by email. [994778] [23-2424] [Christopher Sipes] [Entered: 04/03/2024 11:54 AM] (3) |
| Mar 26, 2024 | 34 | Amended Entry of Appearance for Sara Tonnies Horton; Brian R. Matsui; Devon Wesley Edwards; Dane Douglas Sowers as counsel for Appellee Seagen Inc.. Service: 03/26/2024 by email. [993094] [23-2424] [Brian Matsui] [Entered: 03/26/2024 02:04 PM] (2) |
| Mar 25, 2024 | 33 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Seagen Inc., Entry of Appearance [30], is not in compliance with the rules of this court (see attached). Compliant document due on 04/01/2024. Service as of this date by the Clerk of Court. [992797] [IMH] [Entered: 03/25/2024 03:52 PM] (2) |
| Mar 25, 2024 | 32 | Notice of Related Case Information for Appellee Seagen Inc.. Service: 03/25/2024 by email. [992782] [23-2424] [Sara Horton] [Entered: 03/25/2024 03:32 PM] (2) |
| Mar 25, 2024 | 31 | Amended Certificate of Interest for Appellee Seagen Inc.. Service: 03/25/2024 by email. [992779] [23-2424] [Sara Horton] [Entered: 03/25/2024 03:29 PM] (2) |
| Mar 25, 2024 | 30 | Entry of Appearance for Sara Tonnies Horton; Devon Wesley Edwards; Dane Douglas Sowers as counsel for Appellee Seagen Inc.. Service: 03/25/2024 by email. [992777] [23-2424] This document is non-compliant. See Doc No.[33] [Sara Horton] [Entered: 03/25/2024 03:26 PM] (2) |
| Mar 22, 2024 | 29 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 03/22/2024 by email. [992539]--[Edited 04/01/2024 by GWK - compliance review complete] [Christopher Sipes] [Entered: 03/22/2024 10:43 PM] (0) |
| Mar 22, 2024 | 28 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. Service: 03/22/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [992538] --[Edited 04/01/2024 by GWK to correct docket text- compliance review complete] [Christopher Sipes] [Entered: 03/22/2024 10:40 PM] (373) |
| Mar 22, 2024 | 27 | Entry of Appearance for Jason Fowler as counsel for Appellants Daiichi Sankyo Company, Ltd., AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd.. Service: 03/22/2024 by email. [992352] [23-2424] [Robert Fowler] [Entered: 03/22/2024 11:41 AM] (1) |
| Mar 15, 2024 | 26 | Notice of Related Case Information for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 03/15/2024 by email. [990838] [23-2424] [Christopher Sipes] [Entered: 03/15/2024 10:15 AM] (3) |
| Feb 29, 2024 | 25 | Notice from Appellee Seagen Inc. to Withdraw Michael A. Jacobs as Counsel. Service: 02/29/2024 by email. [987589] [23-2424] [Brian Matsui] [Entered: 02/29/2024 04:18 PM] (2) |
| Dec 27, 2023 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file brief [23] filed by Appellants AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Company, Ltd. and AstraZeneca UK Ltd. The opening brief is due 03/22/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [973062] [MMA] [Entered: 12/27/2023 11:15 AM] (0) |
| Dec 22, 2023 | 23 | MOTION of Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd. to extend the time to 03/22/2024 to file brief. Service: 12/22/2023 by email. [972434] [23-2424] [Christopher Sipes] [Entered: 12/22/2023 01:10 PM] (11) |
| Dec 15, 2023 | 22 | Corrected Certificate of Interest for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 12/15/2023 by email. [970635] [23-2424] [Christopher Sipes] [Entered: 12/15/2023 12:43 PM] (4) |
| Dec 6, 2023 | 21 | Notice of Related Case Information for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 12/06/2023 by email. [968271] [23-2424] [Christopher Sipes] [Entered: 12/06/2023 04:20 PM] (3) |
| Dec 6, 2023 | 20 | Corrected Certificate of Interest for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 12/06/2023 by email. [968260] [23-2424] [Christopher Sipes] [Entered: 12/06/2023 04:15 PM] (4) |
| Dec 6, 2023 | 19 | Corrected Entry of Appearance for Christopher N. Sipes; Bradley K. Ervin; Nicholas Lane Evoy; Adam W. Mitchell as counsel for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 12/06/2023 by email. [968256] [23-2424] [Christopher Sipes] [Entered: 12/06/2023 04:12 PM] (2) |
| Nov 30, 2023 | 18 | Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 11/30/2023 by email. [966790] [23-2424] [Christopher Sipes] [Entered: 11/30/2023 06:06 PM] (2) |
| Nov 29, 2023 | 17 | NOTICE OF NON-COMPLIANCE: The submissions of Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd., Entry of Appearance, and Certificate of Interest [15], [9], are not in compliance with the rules of this court (see attached). Compliant documents due on 12/06/2023. Service as of this date by the Clerk of Court. [966139] [JSP] [Entered: 11/29/2023 09:21 AM] (2) |
| Nov 28, 2023 | 16 | Notice of Related Case Information for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 11/28/2023 by email. [966086] [23-2424] [Christopher Sipes] [Entered: 11/28/2023 08:21 PM] (2) |
| Nov 28, 2023 | 15 | Certificate of Interest for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 11/28/2023 by email. [966084] [23-2424] This document is non-compliant. See Doc No.[17]. [Christopher Sipes] [Entered: 11/28/2023 08:17 PM] (4) |
| Nov 28, 2023 | 14 | Notice of Related Case Information for Appellee Seagen Inc.. Service: 11/28/2023 by email. [966066] [23-2424] [Brian Matsui] [Entered: 11/28/2023 05:34 PM] (2) |
| Nov 28, 2023 | 13 | Docketing Statement for the Appellee Seagen Inc.. Service: 11/28/2023 by email. [966065] [23-2424] [Brian Matsui] [Entered: 11/28/2023 05:32 PM] (3) |
| Nov 28, 2023 | 12 | Certificate of Interest for Appellee Seagen Inc.. Service: 11/28/2023 by email. [966064] [23-2424] [Brian Matsui] [Entered: 11/28/2023 05:28 PM] (2) |
| Nov 28, 2023 | 11 | Entry of Appearance for Brian R. Matsui; Michael A. Jacobs; Bryan Wilson; Matthew A. Chivvis; Matthew I. Kreeger; Seth W. Lloyd as counsel for Appellee Seagen Inc.. Service: 11/28/2023 by email. [966061] [23-2424] [Brian Matsui] [Entered: 11/28/2023 05:25 PM] (2) |
| Nov 28, 2023 | 10 | Docketing Statement for the Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 11/28/2023 by email. [966048] [23-2424] [Christopher Sipes] [Entered: 11/28/2023 04:54 PM] (2) |
| Nov 28, 2023 | 9 | Entry of Appearance for Christopher N. Sipes; Bradley K. Ervin; Nicholas Lane Evoy; Adam W. Mitchell as counsel for Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. and Daiichi Sankyo Company, Ltd.. Service: 11/28/2023 by email. [966043] [23-2424] This document is non-compliant. See Doc No.[17]. [Christopher Sipes] [Entered: 11/28/2023 04:51 PM] (2) |
| Nov 22, 2023 | 8 | Note to File: The following cases shall be considered companion cases and assigned to the same merits panel: 23-2390, 23-2424. [965199] [23-2390, 23-2424] [JSP] [Entered: 11/22/2023 10:31 AM] (0) |
| Nov 22, 2023 | 7 | Note to File: The following cases are consolidated: 23-2424 Lead with 24-1176 member case. The parties must file all documents in the lead appeal only. Appellants' brief is due 01/22/2024 [965167] [23-2424, 24-1176]--[Edited 11/22/2023 by JSP to specify lead case] [JSP] [Entered: 11/22/2023 09:45 AM] (0) |
| Nov 22, 2023 | 6 | ORDER consolidating appeals (23-2424, 24-1176). Appellants' opening brief is due no later than January 22, 2024. Service as of this date by the Clerk of Court. [965164] [23-2424, 24-1176] [JSP] [Entered: 11/22/2023 09:42 AM] (2) |
| Nov 14, 2023 | 5 | ORDER reactivating case under FRAP 4(a)(4). Entry of Appearance due 11/28/2023. Certificate of Interest is due on 11/28/2023. Docketing Statement due 11/28/2023. Appellant/Petitioner's brief is due 01/16/2024. Service as of this date by the Clerk of Court. [963371] [KMH] [Entered: 11/14/2023 02:49 PM] (2) |
| Nov 14, 2023 | 4 | Amended docket sheet from United States District Court for the Eastern District of Texas. [963368] [KMH] [Entered: 11/14/2023 02:42 PM] (43) |
| Sep 26, 2023 | 3 | Clerk's Notice to the Originating Tribunal: Upon disposition of the motion(s) subject to FRAP 4(a)(4), please transmit a certified copy of the docket entries. Service as of this date by the Clerk of Court. [952467] [KMH] [Entered: 09/26/2023 11:55 AM] (1) |
| Sep 26, 2023 | 2 | ORDER deactivating appeal. Service as of this date by the Clerk of Court. [952464] [KMH] [Entered: 09/26/2023 11:53 AM] (2) |
| Sep 26, 2023 | 1 | Appeal docketed. Received: 09/20/2023. [952463]Entry of Appearance due 10/10/2023. Certificate of Interest is due on 10/10/2023. Docketing Statement due 10/10/2023. Appellant/Petitioner's brief is due 11/27/2023. [KMH] [Entered: 09/26/2023 11:50 AM] (114) |
